Stockreport

Fresenius Kabi's Adaptive Nomogram used on Aurora Xi Plasmapheresis System Now Operating Nationwide at BioLife Plasma Centers [Yahoo! Finance]

FRESENIUS SE S/ADR  (FSNUY) 
NASDAQ:AMEX Investor Relations: fresenius.com/index
PDF provider of essential medicines and medical technologies, announced today the successful completion of the U.S. rollout of the Adaptive Nomogram technology used on its A [Read more]